BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12124396)

  • 1. Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53.
    Hansson LO; Friedler A; Freund S; Rudiger S; Fersht AR
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10305-9. PubMed ID: 12124396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.
    Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ
    Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
    Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1alpha and p53: the ODD couple?
    Fels DR; Koumenis C
    Trends Biochem Sci; 2005 Aug; 30(8):426-9. PubMed ID: 15996866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma susceptibility gene product pRB activates hypoxia-inducible factor-1 (HIF-1).
    Budde A; Schneiderhan-Marra N; Petersen G; Brüne B
    Oncogene; 2005 Mar; 24(10):1802-8. PubMed ID: 15674338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes.
    Choi JH; Cho HK; Choi YH; Cheong J
    Biochem J; 2009 Nov; 424(2):285-96. PubMed ID: 19712049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation.
    Fu XS; Choi E; Bubley GJ; Balk SP
    Prostate; 2005 May; 63(3):215-21. PubMed ID: 15538748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae.
    Rajakumar A; Brandon HM; Daftary A; Ness R; Conrad KP
    Placenta; 2004 Nov; 25(10):763-9. PubMed ID: 15451190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level.
    Hubert A; Paris S; Piret JP; Ninane N; Raes M; Michiels C
    J Cell Sci; 2006 Aug; 119(Pt 16):3351-62. PubMed ID: 16882692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha.
    Cho H; Ahn DR; Park H; Yang EG
    FEBS Lett; 2007 Apr; 581(8):1542-8. PubMed ID: 17382325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of natively unfolded HIF-1alpha ODD domain to p53.
    Sánchez-Puig N; Veprintsev DB; Fersht AR
    Mol Cell; 2005 Jan; 17(1):11-21. PubMed ID: 15629713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.
    Koshiji M; To KK; Hammer S; Kumamoto K; Harris AL; Modrich P; Huang LE
    Mol Cell; 2005 Mar; 17(6):793-803. PubMed ID: 15780936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1).
    Wilkins SE; Hyvärinen J; Chicher J; Gorman JJ; Peet DJ; Bilton RL; Koivunen P
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1563-71. PubMed ID: 19401150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How p53 binds DNA as a tetramer.
    McLure KG; Lee PW
    EMBO J; 1998 Jun; 17(12):3342-50. PubMed ID: 9628871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an allosteric binding site on the transcription factor p53 using a phage-displayed peptide library.
    Ravera MW; Cárcamo J; Brissette R; Alam-Moghé A; Dedova O; Cheng W; Hsiao KC; Klebanov D; Shen H; Tang P; Blume A; Mandecki W
    Oncogene; 1998 Apr; 16(15):1993-9. PubMed ID: 9591783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of a consensus binding site for p53.
    el-Deiry WS; Kern SE; Pietenpol JA; Kinzler KW; Vogelstein B
    Nat Genet; 1992 Apr; 1(1):45-9. PubMed ID: 1301998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb.
    Yamane K; Katayama E; Tsuruo T
    Oncogene; 2001 May; 20(23):2859-67. PubMed ID: 11420698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer.
    Schumacher B; Mondry J; Thiel P; Weyand M; Ottmann C
    FEBS Lett; 2010 Apr; 584(8):1443-8. PubMed ID: 20206173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between HIF-1 and Jab1: balancing apoptosis and adaptation. Outline of a working hypothesis.
    Larsen M; Høg A; Lund EL; Kristjansen PE
    Adv Exp Med Biol; 2005; 566():203-11. PubMed ID: 16594154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central region of HDM2 provides a second binding site for p53.
    Yu GW; Rudiger S; Veprintsev D; Freund S; Fernandez-Fernandez MR; Fersht AR
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1227-32. PubMed ID: 16432196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.